These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 35720280)

  • 21. Dissecting human ILC heterogeneity: more than just three subsets.
    Simoni Y; Newell EW
    Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.
    Heinrich B; Gertz EM; Schäffer AA; Craig A; Ruf B; Subramanyam V; McVey JC; Diggs LP; Heinrich S; Rosato U; Ma C; Yan C; Hu Y; Zhao Y; Shen TW; Kapoor V; Telford W; Kleiner DE; Stovroff MK; Dhani HS; Kang J; Fishbein T; Wang XW; Ruppin E; Kroemer A; Greten TF; Korangy F
    Gut; 2022 Jun; 71(6):1161-1175. PubMed ID: 34340996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate lymphoid cells: from helper to killer.
    Krabbendam L; Bernink JH; Spits H
    Curr Opin Immunol; 2021 Feb; 68():28-33. PubMed ID: 32971468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
    Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
    Front Immunol; 2019; 10():217. PubMed ID: 30828332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidimensional molecular controls defining NK/ILC1 identity in cancers.
    Crinier A; Kerdiles Y; Vienne M; Cózar B; Vivier E; Berruyer C
    Semin Immunol; 2021 Feb; 52():101424. PubMed ID: 33272899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
    Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
    Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets.
    Robinette ML; Fuchs A; Cortez VS; Lee JS; Wang Y; Durum SK; Gilfillan S; Colonna M;
    Nat Immunol; 2015 Mar; 16(3):306-17. PubMed ID: 25621825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate Lymphoid Cells in Autoimmune Diseases.
    Clottu AS; Humbel M; Fluder N; Karampetsou MP; Comte D
    Front Immunol; 2021; 12():789788. PubMed ID: 35069567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate Lymphoid Cells and Inflammatory Bowel Disease.
    Peng V; Jaeger N; Colonna M
    Adv Exp Med Biol; 2022; 1365():97-112. PubMed ID: 35567743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate Lymphoid Cells in Cancer.
    Vallentin B; Barlogis V; Piperoglou C; Cypowyj S; Zucchini N; Chéné M; Navarro F; Farnarier C; Vivier E; Vély F
    Cancer Immunol Res; 2015 Oct; 3(10):1109-14. PubMed ID: 26438443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of the Development, Distribution, and Function of Innate-Like Lymphocytes and Innate Lymphoid Cells by the Tissue Microenvironment.
    Ikuta K; Asahi T; Cui G; Abe S; Takami D
    Adv Exp Med Biol; 2024; 1444():111-127. PubMed ID: 38467976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
    Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
    Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of helper innate lymphoid cells in cancer.
    Hu S; Wang X
    Immunotherapy; 2019 Aug; 11(12):1067-1081. PubMed ID: 31238781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Control of Innate Lymphoid Cell Migration.
    Willinger T
    Front Immunol; 2019; 10():2010. PubMed ID: 31507605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Innate Lymphoid Cells: new actors of immunity].
    Cypowyj S; Vivier É
    Bull Acad Natl Med; 2016 Mar; 200(3):561-72; discussion 573-4. PubMed ID: 28644604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate lymphoid cells and cancer.
    Jacquelot N; Seillet C; Vivier E; Belz GT
    Nat Immunol; 2022 Mar; 23(3):371-379. PubMed ID: 35228695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation.
    Tufa DM; Yingst AM; Shank T; Shim S; Trahan GD; Lake J; Woods R; Jones KL; Verneris MR
    Front Immunol; 2019; 10():510. PubMed ID: 30949172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.
    Chen L; Youssef Y; Robinson C; Ernst GF; Carson MY; Young KA; Scoville SD; Zhang X; Harris R; Sekhri P; Mansour AG; Chan WK; Nalin AP; Mao HC; Hughes T; Mace EM; Pan Y; Rustagi N; Chatterjee SS; Gunaratne PH; Behbehani GK; Mundy-Bosse BL; Caligiuri MA; Freud AG
    Immunity; 2018 Sep; 49(3):464-476.e4. PubMed ID: 30193847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of human natural killer cells and other innate lymphoid cells.
    Montaldo E; Vacca P; Moretta L; Mingari MC
    Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryonic ILC-poiesis across tissues.
    Hernández-Torres DC; Stehle C
    Front Immunol; 2022; 13():1040624. PubMed ID: 36605193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.